Project Grant R01AI189662
- Federal Project Grant Award Summary The University of Iowa received a $427,625 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 17, 2025, with a completion date of May 31, 2027. This research project investigates the mechanism of measles virus (MEV) transmission in human airway epithelial cells, specifically examining how MEV rapidly forms infectious centers through an...
- Federal Project Grant Award Summary The University of Iowa received a $499,999 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 22, 2025, with a completion date of July 31, 2026. The grant funds biomedical research investigating how perinatal inflammation directs trained immunity in offspring, specifically examining the mechanisms through which chorioamnionitis—infection...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Iowa a Project Grant totaling $427,625 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 1, 2026, through January 31, 2028. The award funds basic immunology research investigating the molecular mechanisms by which Tumor Necrosis Factor Receptor-Associated Factor 3 (TRAF3) regulates CD4+ T cell differentiation and function...
- Federal Project Grant Award Summary The University of Iowa received a $427,625 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 11, 2026, with completion scheduled for January 31, 2028. This award supports basic biomedical research focused on identifying novel molecular regulators of T follicular helper (TFH) cell differentiation. TFH cells are critical CD4+ T cell...
- Federal Project Grant Award Summary The University of Iowa received a $183,276 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 1, 2025, with completion scheduled for July 31, 2027. This award supports biomedical research investigating hemozoin and liver stage malaria vaccine efficacy. The research addresses a critical public health challenge, as malaria continues to cause...
- Federal Project Grant Award Summary The University of Iowa received a $427,627 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 1, 2025, through June 30, 2027. This award funds biomedical research investigating the role of gamma herpesvirus—specifically Epstein-Barr virus (EBV)—in triggering or augmenting myelin autoimmunity relevant to multiple sclerosis (MS) etiology....
- Federal Grant Award Summary The University of Iowa received a $769,414 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective July 9, 2025, with an ultimate completion date of June 30, 2030. This research award funds investigation into how the cellular protein SAMHD1 (sterile alpha motif and HD domain-containing protein 1) regulates innate immune responses during Human...
- Federal Grant Award Summary The University of Iowa received a $447,169 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 24, 2025, with completion targeted for January 31, 2027. The grant funds research into nanobody-mediated proteolysis of Aspergillus fumigatus transcription factors to advance understanding of fungal pathogenesis mechanisms. The project addresses a...
- Federal Grant Award Summary The University of Iowa received a $649,484 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 10, 2026, with completion scheduled for January 31, 2031. This research project investigates the impact of whole-body radiation exposure on pathogen-specific memory CD8 T cells, addressing a critical knowledge gap in understanding radiation-induced...
- Federal Project Grant Award Summary Iowa State University of Science and Technology received a $1,341,064 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 24, 2025, with a completion date of January 31, 2030. This research project, titled "Mosquito Extracellular Vesicles in Malaria Parasite Killing and Immune Priming," supports fundamental biomedical research aimed...
The University of Iowa received a $791,990 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 4, 2026, through January 31, 2031. The award funds research to explain the mechanisms underlying measles virus (MEV) transmission and its exceptional contagiousness compared to other human respiratory viruses. The research utilizes well-differentiated primary cultures of human airway epithelial cells as a physiologically relevant model system to investigate infectious center formation, viral replication pathways, and host-to-host transmission mechanisms. The project addresses fundamental questions about mitochondrial targeting, mitophagy induction, and intracellular viral assembly while examining how expression of specific MEV proteins (fusion and hemagglutinin) contributes to infectious center formation using adenoviral vector delivery systems. This five-year research initiative directly supports NIAID's mission to advance scientific knowledge of infectious disease mechanisms and develop improved interventions for vaccine-preventable diseases. The research outcomes are expected to provide critical insights into why measles remains the most contagious human virus and could inform the development of enhanced transmission-blocking strategies and improved public health measures for this globally significant pathogen.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $792.0k | 2/4/26 |